Sartorius Stedim Polandsp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in m)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 89 days for 2021). 1 of 6 audited by a statutory auditor.
- 2025not filed
- 202402/09/2025
- 202317/06/2024
- 202203/07/2023
- 202112/10/2022
- 202022/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Public procurement
5 tenders recorded as contractor: 2 national ($116,935) and 3 EU ($607,690).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 21, 2025 | Supply of a platform for purifying letniwirusów | $205.4K$205,412 | Instytut Immunologii i Terapii Doświadczalnej Im. Ludwika Hirszfelda Polskiej Akademii Nauk we Wrocławiu | |
| Oct 8, 2025 | Supply of laboratory equipment for the new Radiogenomics degree programme for the Faculty of Chemistry, divided into lots | $49,096$49,096 | Uniwersytet Warszawski | |
| Oct 1, 2024 | Purchase of bioreactors for cell culture for Instytut Zootechniki – Państwowy Instytut Badawczy | $353.2K$353,182 | Instytut Zootechniki - Państwowy Instytut Badawczy |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by the member of the management board independently. In the case of a multi-member management board, the company is represented by the President of the Management Board or the Vice-President acting independently, or by two members of the management board acting jointly, or by a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sartorius Stedim Biotech Gmbh | 1,600 | $216,099.41 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-01-01.
88 1840 0007 2215 2170 0810 0119- 39 1840 0007 2215 2170 0810 0322
- 56 1840 0007 2215 2170 0810 0210
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| InventionbioS.A. | $17,762,977.76 | inventionbio.pl | ||
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-06-29 | PKD change (Removed: 20.20.Z, 20.42.Z, 20.53.Z) | |
| 2009-09-10 | Share capital change (50,000.00 PLN → 800,000.00 PLN) | |
| 2009-05-15 | Address change (Warszawska 61, 61-028, Poznań → Wrzesińska 70, 62-025, Kostrzyn) | |
| 2008-10-31 | Name change ("sartorius Stedim Poland Spółka Z Ograniczoną Odpowiedzialnością" → Sartorius Stedim Poland) | |
| 2008-08-11 | Entered in the register |
FAQ
Last updated: 2026-10-07